Christopher D. Thibodeau
Plus aucun poste en cours
Profil
Christopher D.
Thibodeau worked as National Director-Sales at US Pathology Labs, Inc., Senior Director-Marketing at Agendia, Inc., Principal at Ventana Medical Systems, Inc., Executive Vice President-Commercial Operations at MDxHealth SA from 2012 to 2015, and Vice President-Sales & Marketing at Numira, Inc. He obtained an undergraduate degree from East Stroudsburg University of Pennsylvania.
Anciens postes connus de Christopher D. Thibodeau
| Sociétés | Poste | Fin |
|---|---|---|
Agendia, Inc.
 Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Sales & Marketing | - |
| MDXHEALTH SA | Directeur des opérations | 30/03/2015 |
US Pathology Labs, Inc.
 US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Sales & Marketing | - |
Ventana Medical Systems, Inc.
 Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Corporate Officer/Principal | - |
Numira, Inc.
 Numira, Inc. Medical/Nursing ServicesHealth Services Numira, Inc. develops and provides molecular imaging technologies for scientific discovery and drug development. Its products include AltaBlu Prime, AltaNexus and AltaViewer. The firm operates as a contract research organization, which provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. The company services include 3D oncology cell screening, histology, image analysis and imaging. Its therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Through the combination of novel software technologies and imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira was founded in 2005 by Michael A. Beeuwsaert and Charles Keller and is headquartered in Salt Lake, UT. | Sales & Marketing | - |
Formation de Christopher D. Thibodeau
| East Stroudsburg University of Pennsylvania | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MDXHEALTH SA | Health Technology |
| Entreprise privées | 4 |
|---|---|
Numira, Inc.
Numira, Inc. Medical/Nursing ServicesHealth Services Numira, Inc. develops and provides molecular imaging technologies for scientific discovery and drug development. Its products include AltaBlu Prime, AltaNexus and AltaViewer. The firm operates as a contract research organization, which provides imaging services for disease research, drug discovery, and pre-clinical studies in animal models. The company services include 3D oncology cell screening, histology, image analysis and imaging. Its therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Through the combination of novel software technologies and imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira was founded in 2005 by Michael A. Beeuwsaert and Charles Keller and is headquartered in Salt Lake, UT. | Health Services |
US Pathology Labs, Inc.
US Pathology Labs, Inc. Medical/Nursing ServicesHealth Services US Pathology Labs, Inc. operates anatomic pathology laboratories. The firm offers diagnosis, prognosis, genomics, and genetic testing services to hospitals, physician offices, surgery centers, and biopharmaceutical companies. The company was founded in 1997 and is headquartered in Irvine, CA. | Health Services |
Ventana Medical Systems, Inc.
Ventana Medical Systems, Inc. Electronic Equipment/InstrumentsElectronic Technology Ventana Medical Systems, Inc. develops tissue-based diagnostic solutions. It designs and delivers medical diagnostic systems and slide-based cancer tests. Its products include absolute Eosinophil count (AEC) detection kit intended for laboratory use to identify targets by immunohistochemistry (IHC) in sections of formalin-fixed, paraffin-embedded tissue or frozen tissue on a BenchMark and BenchMark XT instrument and DISCOVERY XT research instrument that brings automation, reproducibility, and productivity to IHC and in situ hybridization (ISH) slide preparation and processing. The company was founded by Thomas M. Grogan in 1985 and is headquartered in Phoenix, AZ. | Electronic Technology |
Agendia, Inc.
Agendia, Inc. Pharmaceuticals: MajorHealth Technology Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA. | Health Technology |
